- Home
- BOSC vs FGEN Comparison
BOSC vs FGEN Comparison
Compare BOSC & FGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BOSC
- FGEN
- Stock Information
- Founded
- BOSC 1990
- FGEN 1993
- Country
- BOSC Israel
- FGEN United States
- Employees
- BOSC N/A
- FGEN N/A
- Industry
- BOSC Computer Communications Equipment
- FGEN Biotechnology: Pharmaceutical Preparations
- Sector
- BOSC Telecommunications
- FGEN Health Care
- Exchange
- BOSC Nasdaq
- FGEN Nasdaq
- Market Cap
- BOSC 28.4M
- FGEN 33.5M
- IPO Year
- BOSC 1996
- FGEN 2014
- Fundamental
- Price
- BOSC $4.82
- FGEN $5.30
- Analyst Decision
- BOSC
- FGEN Strong Buy
- Analyst Count
- BOSC 0
- FGEN 1
- Target Price
- BOSC N/A
- FGEN $250.00
- AVG Volume (30 Days)
- BOSC 492.7K
- FGEN 53.3K
- Earning Date
- BOSC 08-21-2025
- FGEN 08-05-2025
- Dividend Yield
- BOSC N/A
- FGEN N/A
- EPS Growth
- BOSC 35.10
- FGEN N/A
- EPS
- BOSC 0.49
- FGEN N/A
- Revenue
- BOSC $43,688,000.00
- FGEN $6,996,000.00
- Revenue This Year
- BOSC N/A
- FGEN N/A
- Revenue Next Year
- BOSC N/A
- FGEN N/A
- P/E Ratio
- BOSC $10.32
- FGEN N/A
- Revenue Growth
- BOSC 0.84
- FGEN N/A
- 52 Week Low
- BOSC $2.50
- FGEN $4.50
- 52 Week High
- BOSC $5.50
- FGEN $38.25
- Technical
- Relative Strength Index (RSI)
- BOSC 58.21
- FGEN 31.98
- Support Level
- BOSC $4.63
- FGEN $5.22
- Resistance Level
- BOSC $5.11
- FGEN $5.85
- Average True Range (ATR)
- BOSC 0.26
- FGEN 0.59
- MACD
- BOSC 0.00
- FGEN -0.17
- Stochastic Oscillator
- BOSC 59.46
- FGEN 4.72
About BOSC B.O.S. Better Online Solutions
BOS Better Online Solutions Ltd is a provider of Intelligent Robotics and Supply Chain solutions for enterprises. The company manages its business in three reportable divisions: the Intelligent Robotics segment, the RFID Division segment, and the Supply Chain Solutions segment. The majority of revenue derives from Supply Chain Solutions which distributes electro-mechanical components, mainly to customers in the aerospace, defense, and other industries, and is a supply chain service provider for aviation customers that seek a comprehensive solution to their components-supply needs. Geographically company derives the majority of its revenue from Israel.
About FGEN FibroGen Inc
FibroGen Inc is a biotechnology company focused on discovering, developing, and commercializing novel therapeutics to treat serious cancer biology and anemia. The company operates in one reportable segment: the development and commercialization of novel therapeutics to treat serious unmet medical needs. The company generates the vast majority of its revenue in Europe, followed by Japan. Virtually all of FibroGen's revenue to date has been generated from its collaboration agreements. FibroGen seeks partners with research, development, and marketing capabilities and other resources that strengthen the company's ability to advance product candidates. Geographically, it operates in United States, Japan, Europe and Others.